Search

Search Constraints

You searched for: Author/Creator Alonso, Vicente

Search Results

1. Capecitabine and temozolomide in grade 1/2 neuroendocrine tumors: a Spanish multicenter experience. (March 2017)

2. Gene‐expression signature of tumor recurrence in patients with stage II and III colon cancer treated with 5′fluoruracil‐based adjuvant chemotherapy. Issue 5 (12th August 2012)

3. Guidelines for diagnosis, staging and treatment of metastatic colorectal cancer by Grupo Español Multidisciplinar en Cancer Digestivo (GEMCAD). (April 2015)

4. Lenvatinib in Patients With Advanced Grade 1/2 Pancreatic and Gastrointestinal Neuroendocrine Tumors: Results of the Phase II TALENT Trial (GETNE1509). Issue 20 (10th July 2021)

5. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real‐World Data from the Spanish Tumor Registry (R‐GETNE). (12th January 2018)

6. Phase II Study of Everolimus and Octreotide LAR in Patients with Nonfunctioning Gastrointestinal Neuroendocrine Tumors: The GETNE1003_EVERLAR Study. (23rd May 2018)

7. Preoperative Chemotherapy in Patients With Intermediate-Risk Rectal Adenocarcinoma Selected by High-Resolution Magnetic Resonance Imaging: The GEMCAD 0801 Phase II Multicenter Trial. (10th September 2014)

8. Preoperative Chemotherapy in Patients With Intermediate‐Risk Rectal Adenocarcinoma Selected by High‐Resolution Magnetic Resonance Imaging: The GEMCAD 0801 Phase II Multicenter Trial. (10th September 2014)

9. Prognostic and predictive biomarkers for somatostatin analogs, peptide receptor radionuclide therapy and serotonin pathway targets in neuroendocrine tumours. (November 2018)

10. Prospective Biomarker Study in Advanced RAS Wild‐Type Colorectal Cancer: POSIBA Trial (GEMCAD 10‐02). (24th June 2019)